Synapse - Gunjan Shah

Results (235)

The impact of toxicities on first-year outcomes after ex vivo CD34(+)-selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies

Journal Article

Kosuri, S.; Herrera, D. A.; Scordo, M.; Shah, G. L.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Carlow, D. C.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Re-immunization following autologous hematopoietic stem cell transplantation (Auto HCT) is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance

Meeting Abstract

Shah, G.; Palazzo, M.; Copelan, O.; Seier, K.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)

Meeting Abstract

Shah, G.; Assal, A.; Hsu, M.; Devlin, S.; Hassoun, H.; Korde, N.; Lendvai, N.; Lesokhin, A.; Mailankody, S.; Smith, E.; more...
Clinical Lymphoma, Myeloma and Leukemia (2017)

Fulltext@MSK | Save

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation

Journal Article

Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
Leukemia and Lymphoma (2017)

Fulltext@MSK | Save

Comparable survival and incidence of toxicity for older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M. A.; Nieves, J.; Devlin, S.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
Blood (2016)

Fulltext@MSK | Save

A comprehensive analysis of late toxicities and associated risk factors in long-term survivors of myeloablative conditioned allogeneic hematopoietic cell transplantation using ex-vivo CD34+ selection-based graft-versus-host disease prophylaxis

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Devlin, S.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; Meagher, R. C.; more...
Blood (2016)

Fulltext@MSK | Save

Risk factors predicting outcomes for primary refractory Hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation

Journal Article

Shah, G. L.; Yahalom, J.; Matasar, M. J.; Verwys, S. L.; Goldman, D. A.; Bantilan, K. S.; Zhang, Z.; McCall, S. J.; Moskowitz, A. J.; Moskowitz, C. H.
British Journal of Haematology (2016)

Fulltext@MSK | Save

Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)

Meeting Abstract

Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
Bone Marrow Transplantation (2016)

Fulltext@MSK | Save

Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis